Pages that link to "Q24306987"
Jump to navigation
Jump to search
The following pages link to p53 family members in myogenic differentiation and rhabdomyosarcoma development (Q24306987):
Displaying 50 items.
- Cyclin-dependent kinase 4 (Q14911756) (← links)
- RB transcriptional corepressor 1 (Q21111463) (← links)
- SATB2 augments ΔNp63α in head and neck squamous cell carcinoma (Q24299322) (← links)
- P53 functional abnormality in mesenchymal stem cells promotes osteosarcoma development (Q26771603) (← links)
- Mechanisms of impaired differentiation in rhabdomyosarcoma (Q26852728) (← links)
- p53 suppresses muscle differentiation at the myogenin step in response to genotoxic stress (Q27331653) (← links)
- Tprg, a gene predominantly expressed in skin, is a direct target of the transcription factor p63 (Q28510539) (← links)
- p73 as a pharmaceutical target for cancer therapy (Q28611414) (← links)
- TP63 and TP73 in cancer, an unresolved "family" puzzle of complexity, redundancy and hierarchy (Q33358710) (← links)
- DeltaNp63 is essential for epidermal commitment of embryonic stem cells. (Q33377453) (← links)
- p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner (Q33383860) (← links)
- Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitors (Q33409828) (← links)
- HIPK2 is involved in cell proliferation and its suppression promotes growth arrest independently of DNA damage. (Q33445268) (← links)
- Maged1, a new regulator of skeletal myogenic differentiation and muscle regeneration. (Q33636767) (← links)
- The transient expression of miR-203 and its inhibiting effects on skeletal muscle cell proliferation and differentiation (Q34007761) (← links)
- Characterization of ΔNp73 expression and regulation in gastric and esophageal tumors. (Q34121212) (← links)
- Rb1 loss modifies but does not initiate alveolar rhabdomyosarcoma (Q34255856) (← links)
- Regulation of p53 is critical for vertebrate limb regeneration (Q34375907) (← links)
- Differential regulation of the p73 cistrome by mammalian target of rapamycin reveals transcriptional programs of mesenchymal differentiation and tumorigenesis (Q34550194) (← links)
- Gene expression deregulation in postnatal skeletal muscle of TK2 deficient mice reveals a lower pool of proliferating myogenic progenitor cells (Q34558619) (← links)
- Identification and functional annotation of genome-wide ER-regulated genes in breast cancer based on ChIP-Seq data (Q34560737) (← links)
- Gene expression profiles resulting from stable loss of p53 mirrors its role in tissue differentiation (Q35060929) (← links)
- p73 in Cancer. (Q35103143) (← links)
- p53 Family: Role of Protein Isoforms in Human Cancer (Q35326348) (← links)
- Kras activation in p53-deficient myoblasts results in high-grade sarcoma formation with impaired myogenic differentiation (Q35987311) (← links)
- PAX3-FOXO1 controls expression of the p57Kip2 cell-cycle regulator through degradation of EGR1. (Q36156793) (← links)
- Transcriptional activator TAp63 is upregulated in muscular atrophy during ALS and induces the pro-atrophic ubiquitin ligase Trim63. (Q36673695) (← links)
- p63 and p73 in human cancer: defining the network (Q36749787) (← links)
- A gene signature-based approach identifies mTOR as a regulator of p73. (Q36898974) (← links)
- TAp73β-mediated suppression of cell migration requires p57Kip2 control of actin cytoskeleton dynamics (Q37016573) (← links)
- Mechanisms, function and clinical applications of DNp73. (Q37075900) (← links)
- Prevalence and clinical impact of anaplasia in childhood rhabdomyosarcoma : a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group (Q37307376) (← links)
- The p53 family and programmed cell death (Q37310208) (← links)
- NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma (Q37311506) (← links)
- Antisense gapmers selectively suppress individual oncogenic p73 splice isoforms and inhibit tumor growth in vivo (Q37325404) (← links)
- Advances in pediatric rhabdomyosarcoma characterization and disease model development (Q37580831) (← links)
- Altered S-nitrosylation of p53 is responsible for impaired antioxidant response in skeletal muscle during aging (Q37610209) (← links)
- Molecular and cellular biology of rhabdomyosarcoma. (Q37630588) (← links)
- p53 is balancing development, differentiation and de-differentiation to assure cancer prevention. (Q37760978) (← links)
- Rhabdomyosarcomas: an overview on the experimental animal models. (Q37973827) (← links)
- Myogenic tumors in children and adolescents (Q37993928) (← links)
- Proof-of-concept rare cancers in drug development: the case for rhabdomyosarcoma. (Q38105879) (← links)
- The TP73 complex network: ready for clinical translation in cancer? (Q38126476) (← links)
- The paradigm of mutant p53-expressing cancer stem cells and drug resistance (Q38198487) (← links)
- A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression (Q38266299) (← links)
- p73 poses a barrier to malignant transformation by limiting anchorage-independent growth (Q38294005) (← links)
- Uncovering metabolism in rhabdomyosarcoma. (Q38553827) (← links)
- The Paradox of p53: What, How, and Why? (Q38896065) (← links)
- TAp63gamma is required for the late stages of myogenesis. (Q38897533) (← links)
- PRIMA-1MET/APR-246 targets mutant forms of p53 family members p63 and p73 (Q39659292) (← links)